Periodic Reporting for period 1 - Cancer-Targeted PolyIC (Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC)

We have recently developed a technology that enables targeted delivery of double-stranded RNA, Poly Inosine/Poly Cytosine (PolyIC), into EGFR overexpressing cancers. EGFR is overexpressed in many cancers and therefore has been a target for many drugs. We have shown that...